Hanbury R, Sturiano V, Cohen M, Stimmel B, Aguillaume C
Adv Alcohol Subst Abuse. 1986 Winter;6(2):97-106. doi: 10.1300/J251v06n02_07.
Although cocaine use had increased dramatically among all levels of society over the past several years, its use by heroin addicts has existed for decades. To determine whether the prevalence or the pattern of cocaine use changes once an addict enrolls in methadone maintenance, a survey of cocaine use among persons in methadone maintenance therapy was conducted. Of the 613 persons surveyed, 229 (37%) chose to participate, with 33 (14%) considered invalid because of incomplete responses. Of the remaining 196 (86% of the participants), 64 (33%) indicated no cocaine use prior to methadone maintenance, and 132 (67%) reported some prior use. Once treatment had begun, 9 (14%) with no history of prior use admitted to at least one event within the last 6 months, and 55 (86%) reported no use. Of those reporting use prior to methadone maintenance, 41 (31%) stopped usage and 91 (69%) continued. Of the total participants, approximately half used cocaine at least once during methadone maintenance. Among those who used cocaine before and during methadone maintenance, the predominant route of administration was parenteral, 72 (54%) and 46 (51%) participants, respectively. It should be noted that there was a net gain of 17% of patients who stopped using cocaine as a result of entering methadone maintenance. Indices of cocaine use by random urinalysis over the preceding 6 months, for the entire clinic population, revealed only 86 (14%) to 110 (18%) patients to have urine samples positive for cocaine. Although cocaine use decreased on methadone maintenance, its use is still considerable, with the pattern of use differing from the recreational cocaine use in a non-narcotic-dependent population. Random urinalysis for cocaine appears to be an insensitive indication of prevalence of use.
尽管在过去几年中,可卡因在社会各阶层的使用都急剧增加,但海洛因成瘾者使用可卡因已有数十年历史。为了确定成瘾者进入美沙酮维持治疗后可卡因使用的流行率或模式是否发生变化,对接受美沙酮维持治疗的人员进行了可卡因使用情况调查。在接受调查的613人中,229人(37%)选择参与,其中33人(14%)因回答不完整被视为无效。在其余196人(占参与者的86%)中,64人(33%)表示在接受美沙酮维持治疗之前未使用过可卡因,132人(67%)报告曾有过使用。治疗开始后,9名(14%)无既往使用史的人承认在过去6个月内至少有一次使用,55名(86%)报告未使用。在报告美沙酮维持治疗前有使用史的人中,41人(31%)停止使用,91人(69%)继续使用。在所有参与者中,约一半在美沙酮维持治疗期间至少使用过一次可卡因。在美沙酮维持治疗之前和期间使用可卡因的人中,主要给药途径为非肠道,分别有72名(54%)和46名(51%)参与者。应当指出,因进入美沙酮维持治疗而停止使用可卡因的患者净增17%。对整个诊所人群在前6个月进行的随机尿液分析显示,只有86名(14%)至110名(18%)患者的尿液样本可卡因检测呈阳性。尽管美沙酮维持治疗期间可卡因使用减少,但其使用量仍然可观,使用模式与非麻醉品依赖人群中消遣性使用可卡因的情况不同。对可卡因进行随机尿液分析似乎对使用流行率的指示不敏感。